In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Copernicus Gene Systems Inc.

This article was originally published in Start Up

Executive Summary

Gene Therapy. Copernicus has a DNA compaction technology that can condense DNA fragments and proteins into small bundles for delivery into cells without the use of viral vectors. Also, Copernicus has discovered two new receptor-based targeting systems. One involves a receptor found on the epithelial surface of the lung and the other is found in the liver. Copernicus also has an episomal expression technology.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC089703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel